0920-1050 GenIC Request Template

Request for Approval under the “Generic Clearance for the Collection of Routine Customer Feedback” (OMB Control Number: 0920-1050)

TITLE OF INFORMATION COLLECTION:

OLSR/DLS Project ECHO Biosafety Community of Practice: Demographic and Follow-up Surveys

PURPOSE:

The Development of Biosafety Community of Practice project is based upon the Extension for Community Healthcare Outcomes (ECHO) model and will address laboratory biosafety challenges by bringing together subject matter experts to present and discuss case studies and lessons learned across 12 sessions hosted during 2025. Gathering feedback to improve future sessions is essential to the ECHO model. This evaluation is composed of three different voluntary surveys, including 1) a short demographic survey, 2) a post-session survey, and 3) a follow-up survey after the sixth and twelfth sessions. Holistically, these three surveys will provide feedback from participants to help CDC assess and improve services to target audiences, promote best practices, advance application of laboratory safety, and meet evaluation requirements for use of the ECHO model.

Survey 1 - Participants will be asked to complete a short demographic survey one time over the course of the 12 sessions. The survey should take no longer than 1 minute.

Survey 2 – The post-session survey asks for participant feedback on the session content, presenter, and case-study. Participants will be asked to complete a brief survey for each of the 12 ECHO sessions attended. The survey should take no longer than 2 minutes.

Survey 3 – Participants will be asked to complete a follow-up survey after the sixth and twelfth sessions if they attended sessions during each of these 6-month periods. The survey should take no longer than 2 minutes. Attendees will only be asked to complete a survey for the first 6 or the last 6 sessions of the Biosafety ECHO if they attend one of the sessions in those groupings. For example, if an attendee participates in any of the sessions 1-6 and any of the sessions 7-12, they will complete two surveys. A participant who only attends one session from sessions 1-6 or sessions 7-12 will complete only one survey.

We calculate the total estimated time of 29 minutes to complete these three different evaluation surveys, which includes the maximum number of sessions that an attendee can participate in as follows:

• Survey 1 once after the first session the participant attends: total of 1 minute

• Survey 2 at/after each of the 12 sessions: total of 12 times 2 minutes = 24 minutes

• Survey 3 after the sixth and twelfth sessions: total of 2 times 2 minutes = 4 minutes

DESCRIPTION OF RESPONDENTS:

Respondents will be entirely comprised of laboratory professionals, including but not limited to biosafety officers, quality managers, and laboratory directors. All contacted respondents will have experience with and/or duties related to biosafety in clinical or public health laboratories.

TYPE OF COLLECTION: (Check one)

[ ] Customer Comment Card/Complaint Form [X] Customer Satisfaction Survey

[ ] Usability Testing (e.g., Website or Software [ ] Small Discussion Group

[ ] Focus Group [ ] Other: ______________________

CERTIFICATION:

I certify the following to be true:

1. The collection is voluntary.

2. The collection is low-burden for respondents and low-cost for the Federal Government.

3. The collection is non-controversial and does not raise issues of concern to other federal agencies.

4. The results are not intended to be disseminated to the public.

5. Information gathered will not be used for the purpose of substantially informing influential policy decisions.

6. The collection is targeted to the solicitation of opinions from respondents who have experience with the program or may have experience with the program in the future.

Name: Aufra Araujo, PhD o

To assist review, please provide answers to the following question:

Personally Identifiable Information:

1. Is personally identifiable information (PII) collected? [ ] Yes [X] No

2. If Yes, is the information that will be collected included in records that are subject to the Privacy Act of 1974? [ ] Yes [ ] No

3. If Applicable, has a System or Records Notice been published? [ ] Yes [ ] No Not applicable

Gifts or Payments:

Is an incentive (e.g., money or reimbursement of expenses, token of appreciation) provided to participants? [ ] Yes [X] No

BURDEN HOURS

Burden has been estimated as if all attendees participated in all sessions. However, based on previous collection efforts using the ECHO methodology, attendee participation averaged from 33%-50% of all sessions. The burden estimate below represents the maximal total number of respondents participating in all parts of the information collection.

Category of Respondent	No. of Respondents	No. of Responses per Respondent	Participation Time (hours)	Burden (hours)
State, Local, or Tribal Governments	500	15	2/60	250
Totals				250

FEDERAL COST: The estimated total annual cost to the Federal government is $14,160.00. The cost to the federal government includes the salary of CDC staff and contractors to develop the data collection instrument, collect data, and perform data analysis. There are no equipment or overhead costs.

If you are conducting a focus group, survey, or plan to employ statistical methods, please provide answers to the following questions:

The selection of your targeted respondents

1. Do you have a customer list or something similar that defines the universe of potential respondents and do you have a sampling plan for selecting from this universe? [X] Yes [ ] No

If the answer is yes, please provide a description of both below (or attach the sampling plan)? If the answer is no, please provide a description of how you plan to identify your potential group of respondents and how you will select them?

The CDC Division of Laboratory Systems will collaborate with the Association of Public Health Laboratories to identify personnel from member laboratories, which include state, local and territorial public health laboratories, suitable to participate in ECHO sessions. Identified personnel have experience with and/or subject matter expertise related to Biosafety ECHO sessions. Those who participated in the 2023 and 2024 ECHO Biosafety sessions will also be invited to participate in the 2025 ECHO Biosafety Sessions.

Administration of the Instrument

1. How will you collect the information? (Check all that apply)

[X] Web-based or other forms of Social Media

[ ] Telephone

[ ] In-person

[ ] Mail

[ ] Other, Explain

2. Will interviewers or facilitators be used? [ ] Yes [X] No

Please make sure that all instruments, instructions, and scripts are submitted with the request.

4